A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.

[1]  M. Taheri,et al.  A long non-coding RNA with important roles in the carcinogenesis , 2022, Frontiers in Cell and Developmental Biology.

[2]  S. Ghafouri-Fard,et al.  Identification of expression of CCND1-related lncRNAs in breast cancer. , 2022, Pathology, research and practice.

[3]  Kui-Sheng Chen,et al.  Long non-coding RNA NCK1-AS1 is overexpressed in esophageal squamous cell carcinoma and predicts survival , 2022, Bioengineered.

[4]  Yuanshuai Huang,et al.  LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling. , 2022, Journal of gastrointestinal and liver diseases : JGLD.

[5]  D. Gu,et al.  LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis , 2022, Molecular Biotechnology.

[6]  Juncheng Wang,et al.  Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis , 2022, Journal of biological engineering.

[7]  M. Taheri,et al.  Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia , 2021, Scientific Reports.

[8]  S. Teimourian,et al.  An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer , 2021, Expert review of molecular diagnostics.

[9]  Q. Lin,et al.  NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis , 2021, Cancer cell international.

[10]  X. Zhuang,et al.  AS1 expression in prostate cancer and its effects on proliferation and invasion of prostate cancer cells. , 2021, Cancer biomarkers : section A of Disease markers.

[11]  Jun Ma,et al.  LncRNA NCK1‐AS1 exerts oncogenic property in gastric cancer by targeting the miR‐22‐3p/BCL9 axis to activate the Wnt/β‐catenin signaling , 2021, Environmental toxicology.

[12]  Danhong Zhang,et al.  NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC , 2021, Cancer biology & therapy.

[13]  Huiming Pan,et al.  Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1. , 2021, European Review for Medical and Pharmacological Sciences.

[14]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[15]  M. Taheri,et al.  The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells , 2020, Frontiers in Oncology.

[16]  P. Luo,et al.  LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma , 2020, Journal of biological research.

[17]  Jianqiang Zhao,et al.  Long non-coding RNA NCK1-AS1 promotes the proliferation, migration and invasion of non-small cell lung cancer cells by acting as a ceRNA of miR-137. , 2020, American journal of translational research.

[18]  Pin Lv,et al.  Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis , 2020, OncoTargets and therapy.

[19]  Qiling Xu,et al.  NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Peng Huang,et al.  LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. , 2020, Pathology, research and practice.

[21]  M. Taheri,et al.  Non-coding RNAs are involved in the response to oxidative stress. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Chao Yang,et al.  Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis , 2020, Journal of Experimental & Clinical Cancer Research.

[23]  Qiang Li,et al.  LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143 , 2020, Cancer management and research.

[24]  Haili Hu,et al.  Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a , 2019, Cancer management and research.

[25]  Yi Cheng,et al.  Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells , 2019, OncoTargets and therapy.

[26]  Hua Chang,et al.  NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer. , 2019, Biochemical and biophysical research communications.

[27]  Haikang Zhao,et al.  NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. , 2019, Cancer biotherapy & radiopharmaceuticals.

[28]  J. Pu,et al.  Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia , 2019, Oncology letters.

[29]  Ying-bin Wang,et al.  Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR-613 , 2019, Molecular medicine reports.

[30]  Ping Chen,et al.  Suppression of long noncoding RNA NCK1‐AS1 increases chemosensitivity to cisplatin in cervical cancer , 2018, Journal of cellular physiology.

[31]  Fangzhou Song,et al.  LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway , 2018, Cell Death & Disease.

[32]  Yanxin Li,et al.  TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma , 2017, Nature Communications.

[33]  S. Ghafouri-Fard,et al.  Long Non Coding RNA Expression Intersecting Cancer and Spermatogenesis: A Systematic Review , 2017, Asian Pacific journal of cancer prevention : APJCP.

[34]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.